Regeneron Pharmaceuticals (REGN) insider trading in the last 6 months

5 insiders sold $43.3M. No buys.

Quality Score16Excellent

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 27 tradesSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Form 4 filings, newest first

SellJason Pitofsky$1.1MSVP Controllerat $942.31 on Nov 4, filed Nov 6

SellJason PitofskySVP Controller$1.1Mat $942.31 on Nov 4, filed Nov 6

SellJason Pitofsky$925KSVP Controllerat $941.58 on Nov 4, filed Nov 6

SellJason PitofskySVP Controller$925Kat $941.58 on Nov 4, filed Nov 6

SellJason Pitofsky$541KSVP Controllerat $940.46 on Nov 4, filed Nov 6

SellJason PitofskySVP Controller$541Kat $940.46 on Nov 4, filed Nov 6

From SEC Form 4s, the newest filed Nov 6, 2026 · Insiders have 2 business days to file a trade

24 more filings on REGN in the last 6 months, for Pro members. See them free →

Pro members see every filing on REGN with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Regeneron Pharmaceuticals

Insider trades by person

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about REGN's insider trades

As of Nov 10, 2026: Regeneron Pharmaceuticals (REGN) has 27 insider filings on record in the last 6 months, the newest filed Nov 6, 2026. Its Quality Score is 16 (Excellent). Scores as of 11:01 PM ET, 15 minutes behind.

Are REGN insiders buying or selling?

5 insiders sold $43.3M across 27 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Jason Pitofsky, SVP Controller, sold $1.1M on Nov 4, 2026.

Who are REGN's biggest insider sellers?

By the dollars of their sales in the last 6 months: George L. Sing (Director), 9 sales; Christine A. Poon (Director), 6 sales; Huda Y. Zoghbi (Director), 2 sales. 5 insiders sold in all.

When did an REGN insider last buy?

No REGN insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Jason Pitofsky on Nov 4, 2026.

Regeneron Pharmaceuticals's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.

Regeneron Pharmaceuticals (REGN) insider trading in the last 6 months

Form 4 filings, newest first

Who files at Regeneron Pharmaceuticals

Questions about REGN's insider trades

Every insider trade, with its stock's score.